ArticlePharmaceutical biology2023

Vitexin suppresses the proliferation, angiogenesis and stemness of endometrial cancer through the PI3K/AKT pathway.

Cuixia Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.